Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosis.

ABSTRACT:

SUBMITTER: Boleto G 

PROVIDER: S-EPMC12729254 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature